TozinameranWorsening of chronic graft-versus-host disease and steroid-refractory immune thrombocytopenia: 2 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1905卷 / 1期
关键词：
D O I：
10.1007/s40278-022-14877-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 487
相关论文
共 50 条
  • [41] Treatment of steroid-refractory acute and chronic graft-versus-host disease with ruxolitinib in adults and children
    Moiseev, Ivan
    Morozova, Elena
    Barabanshikova, Maria
    Kozlov, Andrey
    Rudakova, Tatyana
    Klimova, Olesya
    Tcvetkov, Nikolai
    Pirogova, Olga
    Borzenkova, Evgeniya
    Kozhokar, Polina
    Ekushev, Kirill
    Paina, Olesya
    Bykova, Tatyana
    Darskaya, Elena
    Bondarenko, Sergey
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2018, 53 : 461 - 462
  • [42] Ruxolitinib in chronic steroid-refractory graft-versus-host-disease.
    Kovalenko, Iuliia
    Saleem, Tabinda
    Laek, Babray
    Ali, Rimsha
    Mirza, Taaha Muddassir
    Chattaraj, Asmi
    Wahab, Ahsan
    Din, Asma Tamez Ud
    Qurashi, Hafiz
    Golubykh, Konstantin
    Malik, Maidah
    Khan, Rafiullah
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Ruxolitinib as a treatment option for steroid-refractory severe graft-versus-host disease - case report
    Paul, S.
    Wass, M.
    Mueller-Tidow, C.
    Mueller, L. P.
    Oncology Research and Treatment, 2015, 38 : 53 - 53
  • [44] Strategy on the Treatment of Steroid-Refractory Severe acute Graft-versus-Host Disease
    Yamin, T.
    Yi, L.
    Kaili, D.
    He, H.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S393 - S394
  • [45] Treatment of steroid-refractory acute graft-versus-host disease with ATG (Fresenius)
    Kamelander, J.
    Navratil, M.
    Koristek, Z.
    Doubek, M.
    Krejci, M.
    Brychtova, Y.
    Racil, Z.
    Mendelova, D.
    Weinreb, M.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S241 - S241
  • [46] Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease
    Benito, AI
    Furlong, T
    Martin, PJ
    Anasetti, C
    Appelbaum, FR
    Doney, K
    Nash, RA
    Papayannopoulou, T
    Storb, R
    Sullivan, KM
    Witherspoon, R
    Deeg, HJ
    TRANSPLANTATION, 2001, 72 (12) : 1924 - 1929
  • [47] Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
    Meunier, Mathieu
    Bulabois, Claude Eric
    Thiebaut-Bertrand, Anne
    Itzykson, Raphael
    Carre, Martin
    Carras, Sylvain
    Garban, Frederic
    Cahn, Jean Yves
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1451 - 1454
  • [48] How I treat steroid-refractory acute graft-versus-host disease
    Martin, Paul J.
    BLOOD, 2020, 135 (19) : 1630 - 1638
  • [49] Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease
    Rashidi, Armin
    DeFor, Todd E.
    Holtan, Shernan G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2297 - 2302
  • [50] Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease
    Kim, Hyun Min
    Lee, Joonyeop
    Kim, Seokjin
    Lee, Jong Wook
    Kim, Hee-Je
    Cho, Young-Seok
    BLOOD RESEARCH, 2023, 58 (03) : 148 - 148
12345